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ABSTRACT 
Preventing obesity could be done by lowering plasma TAG that inhibits adipogenesis. Oat and mushroom beta-glucans 
in the diet has been reported to lower plasma lipid; however the data focusing on their effects on TAG and obesity are 
insufficient. In the present study, lowering plasma triacylglycerol, fat deposition, body weight gain (BWG) in rats fed a 
high fat diet (HFD) was evaluated. Rats in the control group were given HFD only and rats in the treatment group fed 
HFD enriched with 0.2%, 0.6% and 1.8% (wt:wt) beta-glucan from oats (LD-O, MD-O, HD-O) or mushroom (LD-M, 
MD-M, HD-M). After 6 weeks dietary intervention, the rats fed HD-M showed significantly lower plasma TAG, total 
fat mass, white adipose tissue, inguinal fat and BWG level more than HD-O treated rats (p < 0.05). The underlying 
mechanism in lowering plasma TAG, fat pad masses and BWG in HD-M was increasing ratio of fat faecal to faecal 
weight which was significantly higher than HD-O (p < 0.05). This study demonstrated that the preventing obesity via 
lowering plasma TAG and fat deposition was different depending on beta-glucan origin, either from oats and Shiitake 
mushroom. 
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1. Introduction 
In recent years, the prevalence of obesity has been widely 
reported to induce metabolic syndrome, cardiovascular 
disease, diabetes mellitus and cancer [1-3]. It has been 
reported that lowering plasma triacylglycerol (TAG) 
levels will be efficient in combating body weight gain as 
an increased plasma TAG level was significantly corre- 
lated with increase in body mass index and fat pad masses 
on rats [4]. Beta-glucan is well documented as lowering 
plasma lipids in human [5-8] and animal [9,10] studies.  
Oats and mushrooms have been found to be good 
sources of beta-glucan. An enrichment diet of oats in a 
clinical study was not reported to lower plasma TAG 
levels [11-14] but lowered total plasma cholesterol (TC) 
[11,13]. Limited human studies such as [15] have shown 
the prevention of increased TAG plasma levels using a 
mushroom enriched diet. 
One of the mechanisms of oat beta-glucan in lowering 
plasma lipid is its capacity to increase food viscosity [9, 
10,16]. By increasing viscosity of food in the lumen, 
beta-glucan was reported to prevent and delay the ab- 
sorption of nutrients. However, the viscosity of beta-glu- 
can is dependent on the molecular weight, molecular 
structure, and food matrix [7,10,17].  
While in nearly all of the reported research beta-glucan 
was found to be the main component from oats with the 
potential to lower plasma lipid, in contrast, in research 
using the shiitake mushroom, not only was beta-glucan 
reported to lower lipid, but other nutrient content such as 
eritadenine also lowered plasma lipids [18-20]. Another 
difference between oats and shiitake mushrooms is the 
molecular structure of their beta-glucan [21].  
Thus it will be predicted from compositional data that, 
when comparable amounts of beta-glucan are consumed, 
shiitake mushrooms will lower plasma lipid more effec- 
tively than oats. These predictions are supported by the 
findings of an extraction of each component of shiitake 
mushrooms; for instance, polysaccharide, and eritadenine *Corresponding author. 
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lower plasma TAG by 15% [22], and 39% [23] respec- 
tively. Also reported exoskeleton mushroom contains 
chitin-chitosan lower plasma TAG lipid by 32% [24]. 
To the best of our knowledge, no data are available to 
examine the comparative effect of oats and shiitake 
mushrooms in preventing body weight gain in a similar 
designed study. Such a study would use equivalent do- 
sages of beta-glucan for both the oat and mushroom 
powder, and in addition, the same background high fat 
diet (HFD) would be given and the same type of food 
matrix used to administer the oats and mushrooms. 
The aims of this research were to 1) compare the effect 
of oats and mushrooms powder to prevent body weight 
gain, 2) to determine the effective dose of oat and mush- 
room powder necessary to prevent body weight gain and 
3) to determine the potential underlying mechanisms to 
preventing body weight gain. 
2. Material and Methods 
2.1. Animals and Diet 
Seventy male Wistar rats at 9 weeks of age were pur- 
chased from the Animal Resource Centre (ARC)-Perth, 
Western Australia. All experimental procedures were 
approved by the Animal Ethics Committee of the Uni- 
versity of Wollongong, AE 09/01. The animals were 
housed two rats per cage in environmentally controlled 
conditions (temperature 22˚C, light cycle from 06:00 to 
18:00 hours and dark cycle from 18:00 to 06:00 hours) 
and had ad libitum access to food and water. Rats were 
fed a commercial chow (rat and mouse YS Feed, Young, 
NSW) in order to acclimatise to the new facility and en- 
vironment. The seventy rats were divided into seven 
groups (n = 10) and fed ~50% HFD with additional nil, 
low, medium and high doses of oat powder and Shiitake 
mushroom powder 1) HFD, 2) low dose oat (LD-O), 3) 
medium dose oat (MD-O) and 4) high dose oat (HD-O), 
5) low dose Shiitake mushroom (LD-M), 6) medium 
dose Shiitake mushroom (MD-M), 7) high dose Shiitake 
mushroom (HD-M). Oat bran powder was from OatWell® 
Crea-nutrition and the Shiitake mushroom was from Shen- 
zen Dashan, Food Stuff. Co. Ltd., Shanghai that was im- 
ported by a local store in Australia. The nutrient com- 
position of the oats and mushrooms is shown in Table 1. 
The low, medium and high doses of either oats or mush- 
rooms contain beta-glucan that is comparable to 3, 9 and 
27 g of the beta-glucan requirement for humans, respec- 
tively. The composition of the seven diets is shown in 
Table 2. 
2.2. Body Weight, Food Intake and Fat Pad 
Masses 
Animals were weighed weekly throughout the six week 
intervention period. Food intake was measured every 24 
hours by weighing the amount of total food (g) provided 
to the rats and subtracting the remaining food (g) in the 
cage after 24 hours.  
After completion of food intervention, rats were sacri- 
ficed via carbon dioxide asphyxiation. The white adipose 
tissue (WAT) comprised of visceral fat (epididymal, per- 
irenal, and omental fat) and subcutaneous fat (inguinal 
fat) were then removed and weighed. 
2.3. Plasma Lipid Profile 
Blood samples were obtained by puncturing the right 
ventricle of the heart and collected in EDTA coated tubes 
and centrifuged at 3000 rpm at 22˚C for 25 minute. High 
density lipoprotein (HDL) was isolated from plasma with 
dextran sulphate and magnesium chloride, based on a 
modified method from Sjoblom and Eklund [25]. Total 
plasma cholesterol (TC), TAG, high density lipoprotein 
(HDL) and plasma Non Esterified Fatty acid (NEFA) 
were measured using the Konelab® 20XT automatic ana- 
lyser. The TC, TAG and HDL were analysed with Infin- 
ityTM reagent from Thermo Fisher Scientific (Auburn 
NSW, Australia) and plasma NEFA were analysed use a 
highly specific enzymatic (Wako Chemical, Richmond, 
VA, USA).  
2.4. Viscosity and Molecular Weight (MW) from 
Oat and Mushroom Beta-Glucan 
2.4.1. Extraction of Beta-Glucan 
Beta-glucans were extracted from commercial varieties 
of oats and shiitake mushrooms. Oats and Shiitake mush- 
rooms were pulverized separately using a blender (Bre- 
ville, Sydney, Australia) and sieved through 355 µm 
mesh. Different concentrations of oats and mushrooms 
(Table 3) were prepared by stirring a measured amount 
of each powder in de-ionised water at 70˚C for 30 min- 
utes. The suspensions were then centrifuged in a Sorvall 
RC-5B centrifuge (DuPont Company, Wilmington, Dela- 
ware, USA) at 10,000 rpm for 30 minutes. The clear vis- 
cous supernatant solutions, containing extracted beta-glu- 
cans, were collected for viscosity measurement. 
2.4.2. Viscosity Measurement 
The apparent viscosity of the extract was determined at a 
constant temperature of 37˚C, to mimic the human body 
temperature, using a DV III Rheometer (Brookfield, Mid- 
dleboro, Massachusetts, USA). A water-jacketed sample 
cup was employed to maintain a constant sample tem- 
perature during the measurement. The speed of the rotat- 
ing spindle was increased and then decreased to the 
starting speed. The speeds were chosen so that the torque 
xerted on the liquid was between the manufacturer’s  e   
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Table 1. Nutrient information of OatWell® and Shiitake mushroom. 
Nutritive Value OatWella Shiitake Mushroom 
Chemical Properties Protein (g) 20 20b 
 Carbohydrate (g) 22 32.2b 
 Total dietary fiber (g) 44 33.3b 
 Beta-glucan soluble fibre (g) 22 30c 
 Fat (g) 5 0.7b 
 Energy Kcal or Kj 215/899 282/1178b 
Vitamins and Minerals Sodium (Na) (mg) 8 30d 
 Magnesium (Mg) (mg) 250 1550 [26] 
 Calcium (Ca) (mg) 120 500 [26] 
 Potassium (K) (mg) 680 26.7 [26] 
 Iron (Fe) (mg) 11 33 [26] 
 Zinc (Zn) (mg) 6 92 [26] 
 Vitamin A (µg) NA NA 
 Vitamin B1(mg) 0.3 0.6 [26] 
 Vitamin B2 (mg) NA 1.8 [26] 
 Vitamin B6 (mg) 0.9 NA 
 Vitamin B12 (µg) NA 0.8 [26] 
 Folic Acid (µg) 44 640 [26] 
 Vitamin C (mg) NA 25 [26] 
 Vitamin D (µg) NA 1 µg [26] 
 Vitamin E (delta-alpha-tocopherol) 0.1 mg NA 
Fatty Acids Saturated FA (g) 0.9 0.3d 
 Polyunsaturated FA (g) 2.0 NA 
 Monounsaturated FA (g) 2.1 NA 
Other Specification    
Molecular Weight DA = Dalton = g/Mol 1689.000 [27] >1689.000 
Other Active Components Chitin (%) - 5.36 [28] 
 Eritadenine (%) - 0.3 - 0.63 [29] 
 Chitosan - - 
Data as per 100 g on dry basis. aInformation based on product data sheet OatWell® 22%-Crea Nutrition; bAnalysis 
by Grain Growers Limited (NSW-Australia)/Acc. No. 66; cAnalysis with beta-glucan-glucan KIT from Megazyme 
(K-YBGL 04/2008) (Victoria, Australia); dInformation based on nutrient fact sheet from Shiitake Mushroom Shen- 
zhen Dashan Foodstuff Co. Ltd. NA: Not available. 
recommended ranges of 10% to 100%. At a particular 
speed, the viscosity was measured over the duration of 
10 minutes. For the Shiitake mushroom beta-glucan, the 
minimum and maximum speeds used were 35 rpm (shear 
rate of 263 s–1) and 55 rpm (shear rate of 413 s–1), re- 
spectively, with an increment of 5 rpm. However, for the 
concentration 2 mg/ml, the maximum speed possible 
before the torque exceeded 100% was 45 rpm. For the 
oat beta-glucan, since there was a significant difference 
in viscosity with the change of concentration, the range 
of speed that could be used (ensuring torque was between 
10% - 100%) also differed considerably. For 3 mg/ml, 8 
mg/ml, and 2.5 mg/ml, the speeds used varied from 20 to 
55 rpm, 8 to 45 rpm, and 0.01 to 0.5 rpm, respectively. 
2.4.3. Determination of Molecular Weight 
Molecular weights of the oat and mushroom beta-glucans 
were determined by high performance liquid chromatog- 
raphy (LC-20AT, Shimadzu, Kyoto, Japan) using a re- 
fractive index detector (RID-10A, Shimadzu, Kyoto, 
Japan). Samples of 100 µL were injected into a Waters 
Ultrahydrogel Linear 7.8 × 300 mm size exclusion col- 
umn (Waters, Milford, MA, USA) that was maintained at 
0˚C during measurement. De-ionised water (filtered  5   
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Table 2. Composition of experimental diet. 
Group 
Composition of Experimental Diet 
LDO MDO HDO LDM MDM HDM HFD 
Carbohydrate (% from total energy) 33 33 33 33 33 34 32 
Protein (% from total energy) 16 16 16 16 16 16 16 
Fat (% from total energy) 49 49 48 49 49 48 50 
Fibre (% from total energy) 2 2 3 2 2 3 2 
Additional        
Oat% (wt:wt) 0.9 2.7 8.1 - - - - 
Mushroom% (wt:wt) - - - 0.7 2.1 6 - 
Beta-glucan% (wt:wt) 0.2 0.6 1.8 0.2 0.6 1.8 - 
Daily beta-glucan dose (g) 0.2 ± 0 0.7 ± 0.1 1.9 ± 0.3 0.2 ± 0 0.5 ± 0 1.4 ± 0.1 - 
Energy density (kJ/g) 18.7 18.6 18.0 18.8 18.8 18.4 18.8 
The food was produced from a semi-synthetic material according to the recommendation of “AIN93 diets for laboratory rodents” [30]. 
Table 3. Viscosities of oat and shiitake mushroom solutions 
at different concentrations. The values presented here were 
obtained at 45 rpm, except for high dose oat which was 
obtained at 0.01 rpm. 
Oat Shiitake Mushroom 
Dose Concentration 
(mg/ml) 
Viscosity 
(centipoises)
Concentration 
(mg/ml) 
Viscosity 
(centipoises)
Low 3 1.623 ± 0.004 2 0.812 ± 0.003
Medium 8 6.425 ± 0.018 6 1.056 ± 0.019
High 25 5089 ± 6.932 18 1.332 ± 0.008
 
through a 0.45 µm filter membrane) was the mobile 
phase, set to flow at 0.7 mL/min. The run time per sam- 
ple was 30 minutes. Polyethylene glycol (PEG) with dif- 
ferent molecular weights (1000, 3000, 4000, 6000, and 
8000 dalton) and pure beta-D glucan from Barley (Lot# 
BCBC4494V, Sigma Aldrich, Sydney, Australia) with a 
molecular weight of 230,000 dalton, were used as stan- 
dards. The concentrations of the standards were 15 mg/ml. 
Oat and mushroom beta-glucan extracts, with concentra- 
tions 3 mg/ml and 2 mg/ml respectively (concentration in 
Table 3), were run through the HPLC together with the 
standards. 
2.5. Faecal Weight and Fat Content 
In the last week of intervention, faecal samples were col- 
lected each day for 3 days from all groups. The faecal 
samples from each cage (2 rats per cage) were collected, 
weighed and frozen at –80˚C until analysed for fat con- 
tent. Fat content was analysed according to the modified 
procedure described by [31]. In brief, faeces were dried 
in a freeze dryer for 48 h. The dried faecal samples were 
ground using a mortar and pestle. Fat from the ground 
dried faeces was extracted by stirring in chloroform- 
methanol 2:1, which was mixed well. The supernatant 
was recovered after centrifugation at 3000 rpm for 5 
minute at 22˚C. The supernatant was then dried using a 
stream of nitrogen. The dried fat was weighed using 
analytical balance (AND/HM-300, Japan). The ratio of 
faecal fat to faecal weight was calculated as mg faecal fat 
per g faecal weight. 
2.6. Statistical Analysis 
Data were expressed as mean ± standard error of the 
mean (SEM). Data were analysis by two way ANOVA. 
Dunnet’s method was used to examine the significance 
between the control group (HFD) and the treatment groups. 
To examine the significance among treatment groups, 
contrasts method was used followed by a post hoc-LSD 
test. A p value of 0.05 or less was considered significant. 
Statistical analysis was performed using SAS 9.1 (SAS 
Institute, Cary, NC, USA) and SPSS software (version 
17.0, SPSS Inc., Chicago, IL, USA). 
3. Results 
3.1. Food Intake, Body Weight Gain and Fat 
Mass 
This study compared the dose response effects of oat and 
mushroom enrichment diets on the amount of food intake, 
body weight gain (BWG) and fat deposition of rats fed a 
high-fat diet (HFD). Food intake did not differ among the 
seven groups of dietary intervention (Table 4). The BWG 
was significantly affected by both diets and doses (Table 
4). The rats fed with the mushroom enrichment diet had 
lower BWG compared with the oat enrichment diet (Fig- 
ure 1; p = 0.003). Furthermore, when comparing between 
oats and mushroom powder there was no effect in the 
low dose (p = 0.743), but significant effect in the me-  
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Figure 1. Body weight gain of male Wistar rats after 6 week 
consumption of HFD enriched with oat and mushroom. 
Data expressed as mean (±SEM). (*) significant (p = 0.003). 
: LD; : MD; : HD . 
dium dose (–16%, p = 0.040) and in the high dose (–34%, 
p = 0.002) groups (Figure 1). The total fat deposition 
(epididymal + perirenal + omental + inguinal) was af- 
fected by both diets and doses (Table 5). The rats fed a 
mushroom enrichment diet had significantly lower total 
fat mass than the rats fed an oat enrichment diet (Figure 
2(a), p = 0.001). Furthermore, there was no effect in total  
fat mass when comparing the low dose (p = 0.515) and 
medium dose (p = 0.117) groups, but significant effects 
were seen in the high dose (–41%, p = 0.015) group. 
The WAT was affected by the diets and doses (Table 
5). The rats fed a mushroom enrichment diet had signifi- 
cantly lower WAT than the rats fed an oat enrichment 
diet (Figure 2(b), p = 0.018). Furthermore, there were no 
significant effects in WAT when comparing the low dose 
and medium dose groups but a trend towards an effect in 
the high dose (–32%, p = 0.072) group. The inguinal fat 
mass was affected by the diets and doses (Table 5). The 
rats fed a mushroom enrichment diet had significantly 
lower inguinal fat mass than the rats fed an oat enrich- 
ment diet (Figure 2(c), p = 0.006). Furthermore, there 
were trends towards effects in the low dose (–30%, p = 
0.082), medium dose (–32%, p = 0.086) and high dose 
(–47%, p = 0.078) groups. No statistical differences were 
found in the amount of other fat mass (epididymal, peri- 
renal, omental, and visceral) deposition between rats fed 
a mushroom and rats fed an oat enrichment diet.  
3.2. Plasma Triacylglycerol, Total Cholesterol, 
High Density Lipoprotein, and Non  
Esterified Fatty Acids 
Plasma TAG levels were significantly affected by the 
diets and doses (Table 6). The rats fed a mushroom en-  
 
Table 4. Food intake and body weight gain in rats fed experimental diets. 
Oat group Mushroom group 
Parameter 
LD-O MD-O HD-O LD-M MD-M HD-M 
HFD ANOVA 
Food Intake (g/day) 24 ± 1 26 ± 1 24 ± 1 24 ± 1 24 ± 1 23 ± 1 24 ± 1  
Body weight gain (g) 146 ± 13 179 ± 11# 139 ± 11 141 ± 9 150 ± 14 92 ± 8 129 ± 8 Dt; Ds 
Values are mean (±SEM). Statistical analysis demonstrated # p < 0.05 compared to HFD. ANOVA, analysis of variance (two way); Dt, significant influence of 
diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); HFD, high fat diet; LD-O, low dose oat; MD-O, medium dose oat; HD-O, high dose oat: LD-M, 
low dose mushroom; MD-M, medium dose mushroom; HD-M, high dose mushroom.  
Table 5. Fat pad masses in rats fed experimental diets. 
Oat group Mushroom group 
Parameter 
LD-O MD-O HD-O LD-M MD-M HD-M 
HFD ANOVA 
Epididymal 13 ± 1 14 ± 2 12 ± 1 12 ± 1 13 ± 1 8 ± 1 11 ± 1 Dt 
Perirenal 16 ± 2 15 ± 2 13 ± 2 14 ± 2 13 ± 2 9 ± 1# 14 ± 1 Dt × Ds 
Omental 9 ± 1 11 ± 1 11 ± 2 11 ± 1 11 ± 2 7 ± 1 8 ± 1 Dt × Ds 
Inguinal fat 9 ± 2 10 ± 2 7 ± 2 7 ± 1 7 ± 2 4 ± 0 8 ± 2 Dt:Ds 
Visceral fat (E + P + O) 38 ± 4 40 ± 5 34 ± 4 37 ± 4 34 ± 4 23 ± 2 34 ± 2 Dt, Ds 
White adipose tissue (WAT) 49 ± 5 51 ± 7 41 ± 5 44 ± 4 41 ± 4 28 ± 2 42 ± 3 Dt, Ds 
Total fat masses 49 ± 5 52 ± 7 41 ± 5 44 ±4 41 ± 4 28 ± 2 43 ± 3 Dt, Ds 
ANOVA, analysis of variance (two way): Dt, significant influence of diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); Dt × Ds, significant 
interaction between doses and diet (p < 0.05); HFD, High fat diet; LD-O, low dose oat; MD-O, medium dose oat; HD-O, high dose oat; LD-M, low dose 
ushroom; MD-M, medium dose mushroom; HD-M, high dose mushroom. m    
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Figure 2. The total fat (a); White adipose tissue (WAT) (b) 
and Inguinal fat (c) after 6 week’s consumption of HFD 
enriched with oat and mushroom. Data expressed as means 
(±SEM). (*) significant (a) (p = 0.001); (b) (p = 0.017); (c) (p 
= 0.006). : LD; : MD; : HD.   
richment diet had significantly lower plasma TAG levels 
than the rats fed an oat enrichment diet (Figure 3, p = 
0.004). Furthermore, there were significant effects on  
plasma TAG in rats fed a mushroom enrichment diet in 
low (–25%, p = 0.022), medium (–23%, p = 0.035), and 
high dose (–27%, p = 0.011) groups compared to rats on 
oat enrichment diet. Plasma high density lipoprotein 
(HDL) levels were significantly affected by diet (Table 
6). The rats fed a mushroom enrichment diet had signifi- 
cantly higher plasma HDL levels than the rats fed an oat 
enrichment diet (p = 0.002). There was a trend towards 
higher HDL levels in high doses of mushroom enrich- 
ment diet compared to the oat enrichment diet (+22%, p 
= 0.052). There were no significant effects of diets and 
doses on plasma TC and non esterified fatty acids (NEFA) 
(Table 6). 
3.3. Oat and Mushroom Beta-Glucan Viscosity 
and Molecular Weight 
In order to find the mechanisms for the different effects 
of the oat and mushroom enrichment diets, this study 
characterized the beta-glucan viscosity and molecular  
 
Figure 3. The plasma TAG level after 6 weeks consumption 
of HFD enriched with oat and mushroom. Data expressed 
as means (±SEM). (*) significant (p = 0.004). : LD; : 
MD; : HD. 
 
Table 6. Plasma lipid in rats fed experimental diets. 
Oat group Mushroom group 
Parameter (mmol/L) 
LD-O MD-O HD-O LD-M MD-M HD-M 
HFD ANOVA
TC 1.55 ± 0.06 1.66 ± 0.05 1.64 ± 0.08 1.56 ± 0.05 1.52 ± 0.06 1.54 ± 0.07 1.7 ± 0.07  
TAG 0.84 ± 0.06 0.83 ± 0.10 0.62 ± 1.06 0.63 ± 0.05 0.71 ± 0.08 0.39 ± 0.00# 0.85 ± 0.10 Dt, Ds 
HDL 0.96 ± 0.12 1.05 ± 0.03 1.03 ± 0.03 1.18 ± 0.17 1.06 ± 0.15 1.27 ± 0.06 1.19 ± 0.17 Dt 
NEFA 694 ± 46 723 ± 58 697 ± 51 709 ± 90 709 ± 63 723 ± 83 687 ± 63  
Values are mean (±SEM). Statistical analysis demonstrated # p < 0.05 compared to HFD. ANOVA, analysis of variance (two way): Dt, significant influence of 
diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); TC, total cholesterol; TAG, Triacylglycerol; HDL, high density lipoprotein; NEFA, non esterified 
fatty acid; HFD, high fat diet; LD-O, low dose oat; MD-O, medium dose oat; HD-O, high dose oat; LD-M, low dose mushroom; MD-M, medium dose 
ushroom; HD-M, high dose mushroom. m   
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weight from the oats and mushrooms. Generally, both the 
oat and shiitake mushroom beta-glucans showed sheer 
thinning behavior where the viscosity decreased with 
higher speed. At low speed, they also showed thixotropic 
behavior where the viscosity decreased over time under 
constant shear rate. Due to the variety of speeds used (to 
ensure that the torque exerted on the liquid was between 
the manufacturer’s recommended range), for comparison, 
the viscosity data at 45 rpm is presented (Table 3). At 
this speed, the viscosity of the oat beta-glucan, at the 
concentrations studied in this work, was considerably 
higher than that of the mushroom. The viscosity of mush- 
room beta-glucan even at the highest concentration (18 
mg/ml) was lower than that of oat beta-glucan at the low- 
est concentration (3 mg/ml), suggesting that viscosity is 
not the reason that mushroom beta-glucan is more effec- 
tive to prevent weight gain and fat accumulation than oat 
beta-glucan. The viscosity data of high dose beta-glucan 
in oat solution (25 mg/ml) is shown separately because  
its value is 1000-fold higher (Table 3). Size exclusion 
chromatography data showed that both the Shiitake mush- 
room and oat extracts contained high molecular weight 
polymers, with those from Shiitake mushrooms larger than 
those from oats (Figure 4). 
3.4. The Weight of Faeces and Total Lipid in 
Faeces 
The faecal weights were significantly affected by the 
diets and doses (Table 7). The only diet that was statisti- 
cally different to HFD was HD-O group showing a 24% 
reduction in faecal weight (Table 7).  
The faecal fat weight to faecal weight ratio was sig- 
nificantly affected by doses in rats fed either mushroom 
or oat enrichment diets (Table 7). The faecal fat weight 
to faecal weight ratio was 16% higher in HD-M enrich- 
ment diet compared to HD-O (p = 0.026). However, no 
differences in faecal fat weight to faecal weight ratio  
 
 
Figure 4. The high performance liquid chromatography (HPLC) profiles of β-glucan solutions extracted from oat and shitake 
mushroom and pure β D-glucan from Barley.  
Table 7. Plasma lipid in rats fed experimental diets. 
Oat group Mushroom group 
Parameter 
LD-O MD-O HD-O LD-M MD-M HD-M 
HFD ANOVA 
Faecal weight (g)/24 h 3.9 ± 0 3.5 ± 0.0 3.1 ± 0.2# 3.9 ± 0.1# 3.7 ± 0.2 3.9 ± 0.3 4.1 ± 0 Dt; Ds 
Faecal fat/24 h faecal weight 12 ± 0 13 ± 0 16 ± 0# 12 ± 0 12 ± 0 19 ± 0# 12 ± 0 Ds; Dt × Ds 
Values are mean (±SEM). Statistical analysis demonstrated #p < 0.05 compared to HFD. ANOVA, analysis of variance (two way): Dt, significant influence of 
diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); Dt × Ds, significant interaction between doses and diet (p < 0.05); HFD, high fat diet; LD-O, low 
ose oat; MD-O, medium dose oat; HD-O, high dose oat; LD-M, low dose mushroom; MD-M, medium dose mushroom; HD-M, high dose mushroom. d    
Copyright © 2012 SciRes.                                                                                  FNS 
The Comparison of the Effect of Oat and Shiitake Mushroom Powder to Prevent Body Weight Gain  
in Rats Fed High Fat Diet 
1016 
  
were found between rats fed the same amount of low and 
medium doses of mushroom and oat enrichment diets. 
4. Discussion 
The present study for the first time found that rats fed a 
HFD enriched with shiitake mushroom powder had 
stronger effects in lowering body weight gain, fat deposi- 
tion and plasma TAG, and compared with oat powder. 
To determine the beneficial effect of shiitake mushrooms, 
dosage must also be considered. This study showed that a 
high dose of mushroom enriched diet led to more exclu- 
sion of fat in the faeces compared to a high dose of oat 
enriched diet.  
In general, animal studies have been previously re- 
ported in the literature and these showed that mushroom 
enriched diet had an effect on body weight gain preven- 
tion [24,32-34]. The data of BWG prevention by mush- 
room was depending on the rat species [22,32,34,35], 
dosages in the diet and the variety of mushroom [32,33, 
35-38]. There are no reported clinical trials in mushroom 
enriched diet to prevent BWG in humans. 
The clinical study of oat enriched diet to prevent body 
weight gain was not largely reported, even though oat 
enrichment diet has been studied in different studies with 
different initial plasma lipid levels [5,7,11-14], doses of 
additional oat [8,11,12], length of treatment [5,7,12,13] 
and food matrix [5,7] all of which cannot achieve the 
constructive effect to prevent body weight gain. However 
a clinical study in oat enrichment diet reported decrease 
BWG when oat gives concurrently with exercise and low 
fat diet for 8 weeks [6]. Furthermore enriched oat in ani- 
mal model diet showed decreasing in body weight gain 
when 20% oat bran concentrate enriched diet have 43% 
beta glucan content [10]. However, enrichment 4% and 
8% oat beta glucan for replacing cellulose on hamster fed 
hypercholesterolemic diet did not affect on BWG [39]. 
There are very few studies that investigated the effect 
of oats and mushroom powder as part of a HFD on fat 
deposition. This current study showed that mushroom 
powder (HD-M) was more effective than oat powder (HD- 
O) in lowering total fat mass (35% vs 5%), WAT (33% 
vs 2%) and inguinal fat (50% vs 13%). Similar results 
were reported by [34] an additional 20% of Maitake 
mushrooms in rats fed a cholesterol diet decreased 43% 
fat deposition. On the other hand no studies have re- 
ported the effect of oat enrichment diet on fat deposi- 
tion. 
It has been reported in the literature that mushroom 
and oat enriched diets have the effect of lowering plasma 
TAG in humans and animals. For example, mushroom 
enriched diets significantly lowered plasma TAG level in 
animal studies [22,23,33-35,40] and a human study [15], 
evidence from oat enriched diets showed that more than 
20% of oats in the diet is necessary to achieve TAG low- 
ering effects in rats [9]. Another study reported, the ef- 
fect of an additional 20% oats with different molecular 
weight (370.000 g/mol - 1450.000 g/mol) in mice fed 
HFD had a significant effect on lowering plasma TAG 
level [10]. However, in human studies, additional oats in 
the diet had no effect on plasma TAG lowering effect [5- 
8,11-13,17].  
It is well known that lowering plasma TAG will de- 
crease the fatty acid (FA) circulation, so it will decrease 
the source of fatty acid in adipose tissue through the adi-
pogenesis process [41]. This was also reported by Novelli 
[4] that the increasing of plasma TAG level in rats fed 
HFD promoted fat deposition and BWG.  
This current study showed that HD-M and HD-O re- 
sulted in 58% and 33%, respectively, increase in faecal 
fat excretion per faecal weight compared to HFD. Studies 
have found that 40% oat enriched diets significantly in- 
creased faecal cholesterol fourfold increase in mice fed a 
high fat diet accompanied by a decreased plasma TC and 
TAG levels [9]. A clinical study also reported that an oat 
bran diet in healthy subjects increased fat in faeces 57% 
more than a wheat bran diet [42]. Again, Cheung [36] 
reported hamsters fed HFD and Straw mushrooms en- 
richment significantly increased faecal sterol 81% more 
than hamsters fed the control diet (HFD and cellulose) 
which was accompanied by a significant 36% TC lower- 
ing effect.  
Some studies reported the improvement in dyslipi- 
daemia by beta-glucan was due to viscosity [7,16,17]. 
Both beta-glucan from oats [43,44] and mushrooms [45] 
can slow down the digestion transit time in the lower part 
of the small intestine and in the large intestine, therefore 
delaying nutrient absorption. This study measured both 
oat and mushroom beta-glucan molecular weight before 
these were added and mixed to the rat food. The results 
showed that MW in Shiitake mushroom beta glucan was 
higher than oat beta glucan used in this study. However, 
it is uncertain whether the viscosity of oats or mush- 
rooms alone would be similar to the actual viscosity of 
rat food after it was added to oats or Shiitake mushrooms. 
This is because in food enriched with oats and Shiitake 
mushrooms viscosity was affected by the food prepara- 
tion, such as food stored in a frozen state, and the diges- 
tion process that could decrease the MW of beta-glucan.  
For instance, the freeze-thaw process will decrease 
MW by 40% and the digestion process will decrease by 
100,000 Dalton [46]. In this study, the rat foods were 
frozen before being given to rats. As the mushroom MW 
was greater than oat MW, after the freeze-thaw process 
and digestion, the MW of the oats was expected to re- 
main <1,000,000 Dalton and the MW of the mushrooms 
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was expected to remain >1,000,000 Dalton. Although the 
correlation of MW and the effect of viscosity were still 
doubtful, Tosh, Brummer et al. [47] reported that in or- 
der to achieve the viscosity effect of beta-glucan, the 
MW should be >1,000,000 Dalton. Kerckhoffs, Hornstra 
et al. [7] also reported that a MW of beta-glucan 
<1,200,000 Dalton could still lower plasma lipid if ad- 
ministered with a drink. Therefore the viscosity in oats 
and Shiitake mushrooms tested before they were added 
to the rat food may not be able to explain the different 
effects of oat and Shiitake mushroom enriched diets in 
lowering plasma lipid levels in vivo.  
Shiitake mushroom powder contains other active in- 
gredients such as eritadenine and chitin. Eritadenine may 
contribute to the effect by inhibiting the plasma TAG 
derived lipoprotein release from the liver [48,49]. The 
concentration of eritadenine is about 0.36% in Shiitake 
mushroom powder [29]. The HD-M diet used in this 
study contains ~200 mg eritadenine/kg food. Sugiyama 
[18] reported that an additional 50 mg eritadenine in cho- 
line deficient rats lowered plasma lipid by –68% and 
–83% of plasma TC and TAG respectively.  
Chitin is insoluble in water and grouped as functional 
fibre to lower blood lipids [50,51]. However, chitin needs 
to be converted to chitosan to lower plasma lipid levels 
[52]. The process of converting chitin to chitosan is by 
alkaline hydrolysis (45% NaOH, 100˚) [53]. Hence this 
conversion is unlikely to have occurred in vivo, and there- 
fore chitin is unlikely to explain the reduction in plasma 
TAG in this study.  
Accordingly, this result and references suggest the 
lowering of plasma TAG levels in HD-M has possibly 
also been affected by eritadenine. This reason was sup- 
ported by data that showed that although the fat faecal 
exclusion both of HD-M and HD-O were not signifi- 
cantly different the plasma TAG level, fat mass deposi- 
tion and body weight gain between HD-O and HD-M 
were significantly different. Therefore other mechanisms 
possibly promoted the lowering of plasma TAG levels in 
HD-M. 
5. Conclusion 
In summary, the mushroom diet is better than the oat diet 
as part of a HFD because it reduces BWG, total fat mass, 
plasma TAG and increased fat faecal excretion. The 
dosage required for these effects was the HD-M (1.8% 
wt:wt beta glucan from mushroom or 6% mushroom 
powder) with lower doses having minimal effects. The 
potential reason why mushrooms were better than oats 
was possibly its chemical structure. Food enriched with 
Shiitake mushroom was more stable and retained viscos- 
ity effects after the freeze-thaw process compared to food 
enriched with oats. In addition, Shiitake mushrooms also 
contain another potential biological component, namely 
eritadenine. 
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